{
  "id": 5895,
  "url": "https://nnemf.org/research/5895-sinusoidal-extremely-low-frequency-electromagnetic-stimulation-elf-ems",
  "title": "Sinusoidal Extremely Low-Frequency Electromagnetic Stimulation (ELF-EMS) Promotes Angiogenesis In Vitro.",
  "authors": [
    "Lena Perez Font",
    "Amanda Moya-Gomez",
    "Hannelore Kemps",
    "Ivo Lambrichts",
    "Jean-Michel Rigo",
    "Bert Brône",
    "Annelies Bronckaers"
  ],
  "journal": "Biomedicines",
  "year": "2025",
  "doi": "10.3390/biomedicines13061490",
  "pmid": "40564209",
  "abstract": ": Angiogenesis is the multistep process of the formation of new blood vessels. It is beneficial in scenarios that require tissue repair and regeneration, such as wound healing, bone fracture repair, and recovery from ischemic injuries like stroke, where new blood vessel formation restores oxygen and nutrient supply to damaged areas. Extremely low-frequency electromagnetic stimulation (ELF-EMS), which involves electromagnetic fields in the frequency range of 0-300 Hz, have been shown to reduce ischemic stroke volume by improving cerebral blood flow and recovery effects that are dependent on eNOS. Based on previous results, we herein explore the effects of ELF-EMS treatment (13.5 mT/10 and 60 Hz) on the activation of angiogenic processes in vitro in homeostatic conditions. : Using human microvascular endothelial cells (HMEC-1), we studied cell proliferation, migration, and tube formation in vitro, as well as nitric oxide production and the effect of calcium and nitric oxide (NO) on these processes. Moreover, blood vessel formation was studied using a chicken chorioallantoic membrane (CAM) assay. : Our results showed that ELF-EMS increases proliferation, tube formation, and both the migration and transmigration of these cells, the latter of which was mediated via NO. In turn, calcium inhibition decreased ELF-EMF-induced NO production. Furthermore, ELF-EMS significantly increased blood vessel formation in the CAM assay. : Our results indicated that ELF-EMS exposure (13.5 mT/10 and 60 Hz) significantly induces angiogenesis in vitro and in ovo, underscoring its potential application in the treatment of conditions characterized by insufficient blood supply.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "in_vitro",
    "studyTypeLabel": "In vitro study",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Human microvascular endothelial cells (HMEC-1); chicken chorioallantoic membrane (CAM) assay (in ovo)",
    "sampleSize": "—",
    "exposure": "ELF <1 MHz",
    "confidencePct": "78",
    "peerReviewed": "yes",
    "mainFindings": "ELF-EMS (13.5 mT at 10 and 60 Hz) increased HMEC-1 proliferation, tube formation, migration and transmigration; transmigration was reported as mediated via nitric oxide (NO). Calcium inhibition decreased ELF-EMF-induced NO production, and ELF-EMS increased blood vessel formation in the CAM assay.",
    "outcomes": [
      "Endothelial cell proliferation",
      "Endothelial cell migration",
      "Endothelial cell transmigration",
      "Tube formation",
      "Nitric oxide (NO) production",
      "Calcium involvement in NO production",
      "Blood vessel formation (CAM assay)"
    ],
    "limitations": [
      "In vitro and in ovo models",
      "no human clinical outcomes reported in the abstract",
      "Exposure duration not reported in the abstract",
      "Sample sizes and quantitative effect estimates not reported in the abstract"
    ],
    "keywords": [
      "angiogenesis",
      "extremely low-frequency",
      "ELF-EMS",
      "electromagnetic stimulation",
      "13.5 mT",
      "10 Hz",
      "60 Hz",
      "HMEC-1",
      "endothelial cells",
      "tube formation",
      "migration",
      "nitric oxide",
      "calcium",
      "CAM assay"
    ],
    "hubs": [
      {
        "slug": "occupational-exposure",
        "weight": "0.7",
        "reason": "Uses ELF electromagnetic fields; however this is a stimulation/biomedical context rather than occupational exposure."
      }
    ],
    "raw": "{\n  \"study_type\": \"in_vitro\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": \"electromagnetic stimulation (ELF-EMS)\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Human microvascular endothelial cells (HMEC-1); chicken chorioallantoic membrane (CAM) assay (in ovo)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Endothelial cell proliferation\",\n    \"Endothelial cell migration\",\n    \"Endothelial cell transmigration\",\n    \"Tube formation\",\n    \"Nitric oxide (NO) production\",\n    \"Calcium involvement in NO production\",\n    \"Blood vessel formation (CAM assay)\"\n  ],\n  \"main_findings\": \"ELF-EMS (13.5 mT at 10 and 60 Hz) increased HMEC-1 proliferation, tube formation, migration and transmigration; transmigration was reported as mediated via nitric oxide (NO). Calcium inhibition decreased ELF-EMF-induced NO production, and ELF-EMS increased blood vessel formation in the CAM assay.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"In vitro and in ovo models; no human clinical outcomes reported in the abstract\",\n    \"Exposure duration not reported in the abstract\",\n    \"Sample sizes and quantitative effect estimates not reported in the abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.78,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"angiogenesis\",\n    \"extremely low-frequency\",\n    \"ELF-EMS\",\n    \"electromagnetic stimulation\",\n    \"13.5 mT\",\n    \"10 Hz\",\n    \"60 Hz\",\n    \"HMEC-1\",\n    \"endothelial cells\",\n    \"tube formation\",\n    \"migration\",\n    \"nitric oxide\",\n    \"calcium\",\n    \"CAM assay\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"occupational-exposure\",\n      \"weight\": 0.1,\n      \"reason\": \"Uses ELF electromagnetic fields; however this is a stimulation/biomedical context rather than occupational exposure.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/40564209/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=5895",
  "updated": "2026-02-14 08:54:51"
}